Financials Dr. Martens plc

Equities

DOCS

GB00BL6NGV24

Footwear

Market Closed - London S.E. 16:35:17 14/06/2024 BST 5-day change 1st Jan Change
80.3 GBX -4.52% Intraday chart for Dr. Martens plc -5.92% -9.37%

Valuation

Fiscal Period: März 2021 2022 2023 2024 2025 2026 2027
Capitalization 1 4,532 2,388 1,424 844 772.5 - -
Enterprise Value (EV) 1 4,706 2,554 1,712 844 1,114 1,119 1,101
P/E ratio 126 x 13.2 x 11 x 12.5 x 27.2 x 13.7 x 10.2 x
Yield - 2.3% 4.1% - 3.22% 3.67% 3.43%
Capitalization / Revenue 5.86 x 2.63 x 1.42 x 0.96 x 0.92 x 0.87 x 0.8 x
EV / Revenue 6.09 x 2.81 x 1.71 x 0.96 x 1.33 x 1.26 x 1.14 x
EV / EBITDA 21 x 9.71 x 6.99 x 4.27 x 7.7 x 5.79 x 5.07 x
EV / FCF 27.7 x 19.3 x 66.1 x - 14.6 x 13.4 x 9.92 x
FCF Yield 3.61% 5.17% 1.51% - 6.83% 7.46% 10.1%
Price to Book 30.1 x 7.3 x 3.52 x - 2.03 x 1.87 x 1.64 x
Nbr of stocks (in thousands) 1,000,000 1,000,111 1,000,770 961,879 961,972 - -
Reference price 2 4.532 2.388 1.423 0.8775 0.8030 0.8030 0.8030
Announcement Date 17/06/21 01/06/22 01/06/23 30/05/24 - - -
1GBP in Million2GBP
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2020 2021 2022 2023 2024 2025 2026 2027
Net sales 1 672.2 773 908.3 1,000 877.1 838 890.5 967.7
EBITDA 1 - 224.2 263 245 197.5 144.7 193.4 217.3
EBIT 1 - 193 229.3 176.2 122.2 68.22 108.5 126.2
Operating Margin - 24.97% 25.24% 17.61% 13.93% 8.14% 12.18% 13.04%
Earnings before Tax (EBT) 1 - 70.9 214.3 159.4 93 39.31 75.4 105.6
Net income 1 74.8 35.7 181.2 128.9 69.2 28.71 55.03 77.1
Net margin 11.13% 4.62% 19.95% 12.89% 7.89% 3.43% 6.18% 7.97%
EPS 2 - 0.0360 0.1810 0.1290 0.0700 0.0296 0.0587 0.0790
Free Cash Flow 1 - 169.8 132.1 25.9 - 76.1 83.5 111
FCF margin - 21.97% 14.54% 2.59% - 9.08% 9.38% 11.47%
FCF Conversion (EBITDA) - 75.74% 50.23% 10.57% - 52.58% 43.18% 51.07%
FCF Conversion (Net income) - 475.63% 72.9% 20.09% - 265.03% 151.75% 143.97%
Dividend per Share 2 - - 0.0550 0.0584 - 0.0258 0.0295 0.0276
Announcement Date 02/10/20 17/06/21 01/06/22 01/06/23 30/05/24 - - -
1GBP in Million2GBP
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: March 2021 S2 2022 S1 2022 S2 2023 S1 2023 S2 2024 S1 2024 S2
Net sales 1 454.8 369.9 538.4 418.6 581.7 395.8 481.3
EBITDA 1 - 88.8 - 88.8 - 77.6 119.9
EBIT - - - - - 40.3 -
Operating Margin - - - - - 10.18% -
Earnings before Tax (EBT) - - - - - 25.8 -
Net income - - - - - - -
Net margin - - - - - - -
EPS - - - - - 0.0190 -
Dividend per Share - - - - - 0.0156 -
Announcement Date 17/06/21 09/12/21 01/06/22 24/11/22 01/06/23 30/11/23 30/05/24
1GBP in Million
Estimates

Balance Sheet Analysis

Fiscal Period: March 2020 2021 2022 2023 2024 2025 2026 2027
Net Debt 1 - 174 166 288 - 342 346 329
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) - 0.7756 x 0.6304 x 1.177 x - 2.362 x 1.791 x 1.514 x
Free Cash Flow 1 - 170 132 25.9 - 76.1 83.5 111
ROE (net income / shareholders' equity) - 105% 75.8% 35.2% - 7.94% 16.2% 17.4%
ROA (Net income/ Total Assets) - - - - - 3.02% 5.39% -
Assets 1 - - - - - 949.6 1,021 -
Book Value Per Share 2 - 0.1500 0.3300 0.4000 - 0.4000 0.4300 0.4900
Cash Flow per Share 2 - 0.1600 0.1800 0.0800 - 0.1500 0.1600 -
Capex 1 - 18.6 25 51.4 - 44.2 48.7 48
Capex / Sales - 2.41% 2.75% 5.14% - 5.27% 5.47% 4.96%
Announcement Date 02/10/20 17/06/21 01/06/22 01/06/23 30/05/24 - - -
1GBP in Million2GBP
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
8
Last Close Price
0.803 GBP
Average target price
0.7686 GBP
Spread / Average Target
-4.28%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. DOCS Stock
  4. Financials Dr. Martens plc
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW